Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain.
Osmotic Demyelination Syndrome Secondary to Hypernatremia and Hypokalemia: A Case Report of Complete Recovery.
Adenosine 2A receptor drives microglial efferocytosis to accelerate white matter repair and functional recovery after stroke.
Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease.
Brain energy metabolism changes and neuropsychological impairment in Parkinson disease vs Alzheimer disease.
Advanced MRI in Multiple Sclerosis: Clinical Translation of Imaging Biomarkers in the 2024 McDonald Criteria.
Dynamics of Myelin-Specific T-Cell Repertoires Mirror Disease Activity and Central Nervous System Trafficking in Multiple Sclerosis.
Disability and race in MS: Does socioeconomic disadvantage play a role?
Near‑Infrared Photobiomodulation in White‑Matter Disease: From Microglial States to Measurable Endpoints.
New variant in PLP1 gene associated with X-linked spastic paraplegia type 2: First report of a family in Colombia.
Preventing physical and chemical degradation of the LABL-Fc-MOG, a bifunctional peptide inhibitor, with formulation development approaches.
Genetic and molecular architecture of multiple sclerosis in gulf cooperation council populations: A scoping review and regional precision-neurology perspective.
Association of epiretinal membranes with disability in people with multiple sclerosis.
Guillain-Barré syndrome following Plasmodium falciparum malaria in a child: a case report.
Mental health comorbidity and multiple sclerosis outcomes: Clarifying progression through longitudinal, imaging, and equity-focused markers.
Structure function relationships differ between optic neuritis and glaucoma with comparable optical coherence tomography findings.
Comparative Efficacy of Type I Interferons and Monoclonal Antibodies in Experimental Autoimmune Uveitis: A Systematic Review and Meta-Analysis.
Targeting progressive multiple sclerosis: Toward mechanism-informed precision medicine.
A mathematical model for inflammation and demyelination in multiple sclerosis.
Molecular Tumor Board: H3K27M Diffuse Midline Glioma Diagnosed During Pregnancy by Cerebrospinal Fluid Next-Generation Sequencing.
Reply to "Trigeminal root dislocation subtends focal demyelination of primary trigeminal afferents in patients with trigeminal neuralgia".
Ocrelizumab-induced colitis acutely managed with ciclosporin.
Modulation of TH17 cell activity by REV-ERB agonists: path toward novel treatments for canine meningoencephalitis of unknown origin.
Network dynamics under neuronal degradation: A comparison between modular and small-world topologies.
Transient Visual Obscurations and Systemic Symptoms Unveiling Glial Fibrillary Acidic Protein Astrocytopathy.
Pages
« first
‹ previous
…
912
913
914
915
916
917
918
919
920
…
next ›
last »